Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal thrombocytopenia.

Irene A G Roberts1, Neil A Murray

  • 1Imperial College School of Medicine, Hammersmith Hospital, London W12 ONN, UK. irene.roberts@imperial.ac.uk

Current Hematology Reports
|March 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma.

Blood·2022
Same author

Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma.

Nature communications·2021
Same author

High resolution IgH repertoire analysis reveals fetal liver as the likely origin of life-long, innate B lymphopoiesis in humans.

Clinical immunology (Orlando, Fla.)·2017
Same author

Cell-type-specific transcriptional regulation of PIGM underpins the divergent hematologic phenotype in inherited GPl deficiency.

Blood·2014
Same author

Activated invariant NKT cells regulate osteoclast development and function.

Journal of immunology (Baltimore, Md. : 1950)·2011
Same author

Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2009
Same journal

Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.

Current hematology reports·2006
Same journal

The treatment of immune thrombocytopenic purpura in children.

Current hematology reports·2006
Same journal

Volume-reduced platelet concentrates.

Current hematology reports·2006
Same journal

Platelet transfusions in infants with necrotizing enterocolitis.

Current hematology reports·2006
Same journal

Methods for counting platelets in severe thrombocytopenia.

Current hematology reports·2006
Same journal

Flow cytometry for the diagnosis of autoimmune thrombocytopenia.

Current hematology reports·2006
See all related articles

Neonatal thrombocytopenia, a common issue, requires better transfusion guidelines. Current platelet transfusion thresholds for sick newborns are unclear, highlighting the urgent need for evidence-based trials to improve outcomes.

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Pediatric Critical Care

Background:

  • Neonatal thrombocytopenia is a frequent clinical challenge with diverse causes.
  • Early-onset thrombocytopenia often stems from placental insufficiency, while late-onset cases are frequently linked to sepsis or necrotizing enterocolitis.
  • Profound thrombocytopenia in unstable neonates is associated with poor outcomes.

Purpose of the Study:

  • To review the current understanding of neonatal thrombocytopenia.
  • To highlight the lack of evidence-based guidelines for platelet transfusion in sick neonates.
  • To emphasize the critical need for randomized trials to establish safe platelet count thresholds.

Main Methods:

  • This review synthesizes existing literature on neonatal thrombocytopenia.

Related Experiment Videos

  • It analyzes common etiologies and clinical presentations.
  • It critically evaluates current transfusion practices and identifies research gaps.

    • Main Results:

    • Common causes include placental insufficiency, immune thrombocytopenias, congenital infections, asphyxia, bacterial sepsis, and necrotizing enterocolitis.
    • Platelet transfusion is the primary therapy, but optimal thresholds remain undefined.
    • No randomized trials exist to guide transfusion decisions in sick neonates.

    Conclusions:

    • The optimal platelet transfusion threshold for sick neonates is currently unknown.
    • Existing guidelines lack robust evidence from randomized controlled trials.
    • Urgent, well-designed trials are essential to define safe and effective platelet transfusion strategies for neonatal thrombocytopenia.